A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy And Safety Of Lumateperone For The Treatment Of Major Depressive Episodes (Mdes) Associated With Bipolar I Or Bipolar II Disorder (Bipolar Depression) In Pediatric
Posted Date: Jan 7, 2025
- Investigator: Melissa Delbello
- Specialties: Adolescent Psychiatry/Psychology, Bipolar Disorder, Depression, Psychiatry/Psychology
- Type of Study: Drug
The purpose of this clinical research study is to understand how effective and safe an investigational study drug called lumateperone is and whether it works when given to young people (10–17 years of age) with major depressive episodes associated with bipolar disorder.
Criteria:
Null
Keywords:
Depression, Bipolar Disorder, Pediatric
For More Information:
Maria Mastroianni
513 558-8950
maria.mastroianni@uc.edu